In this article, we will discuss 11 Best Low Priced Growth Stocks to Buy Right Now.
Low-priced growth stocks, specifically those combining a low forward P/E ratio with strong or accelerating Earnings Per Share (EPS), offer a compelling blend of value and momentum. A low forward P/E suggests investors are paying a relatively modest price for each dollar of expected future earnings, potentially signaling undervaluation or overly cautious market expectations. At the same time, high or rapidly growing EPS indicates that the company is generating substantial profits and improving its operational efficiency. When these two characteristics align, investors gain exposure to businesses that are not only expanding earnings but are also trading at reasonable (or even discounted) valuations.
This combination can create a powerful setup for outperformance. If earnings continue to grow as projected, the stock benefits from fundamental profit expansion. If the market reassesses the company’s prospects more positively, the valuation multiple may also expand, delivering an additional layer of upside. In other words, investors may capture both earnings growth and multiple re-rating. Furthermore, strong EPS provides flexibility for reinvestment, debt reduction, or dividend growth, reinforcing financial stability while supporting long-term shareholder returns.
By focusing on companies that exhibit both growth and valuation discipline, investors position themselves to benefit from improving fundamentals without overpaying for future potential, an approach that balances opportunity with margin of safety.
With this context in mind, here is a list of the 11 best low priced growth stocks to buy right now.
Our Methodology
We used screeners to identify stocks that have a track record of delivering earnings growth and have grown their EPS by at least 20% over the past 3 years. From this pool, we focused on equities that are trading at a forward P/E of less than 15 and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. We ranked these stocks in ascending order of their forward P/E. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
11 Best Low Priced Growth Stocks to Buy Right Now
11. Vital Farms, Inc. (NASDAQ:VITL)
EPS Growth in 3 years: 176.28%
Forward P/E: 14.28
On February 26, Benchmark downgraded Vital Farms, Inc. (NASDAQ:VITL) to Hold from Buy and removed its price target following the company’s issuance of what the firm characterized as a “volatile” Q1 outlook. Benchmark cited tempered FY26 revenue growth expectations and guidance for sharp margin compression as drivers of increased uncertainty. While the firm remains highly convinced in the long-term strength of Vital Farms’ brand and revenue growth trajectory, it believes near-term margin pressure and diminished credibility outweigh the positives at present, suggesting the situation may require several quarters to stabilize.
That same day, Vital Farms, Inc. (NASDAQ:VITL) reported Q4 revenue of $213.55 million, modestly ahead of consensus estimates of $212.83 million. Management stated that 2025 marked a pivotal year in scaling the company’s supply chain to meet demand. The expansion of Egg Central Station and the growth of its farmer network to over 600 small farms significantly reduced prior supply constraints that had limited growth. These operational investments enhanced production capacity and positioned the company for improved demand fulfillment, though near-term profitability remains under pressure.
Additionally, Vital Farms, Inc. (NASDAQ:VITL) announced an orderly transition in board leadership. Founder Matt O’Hayer stepped down as executive chairperson and board member effective February 24, transitioning to a non-employee advisory role. The board appointed President and CEO Russell Diez-Canseco to serve as executive chairperson, consolidating leadership responsibilities as the company navigates its next operational phase.
Vital Farms, founded in 2007 and headquartered in Austin, Texas, is a leading U.S. food company specializing in ethically produced, pasture-raised eggs and butter. Partnering with hundreds of small family farms nationwide, the company emphasizes animal welfare standards while distributing responsibly sourced products across major U.S. retail channels.
10. Salesforce, Inc. (NYSE:CRM)
EPS Growth in 3 years: 234.40%
Forward P/E: 13.34
On February 26, Piper Sandler lowered the firm’s price target on Salesforce, Inc. (NYSE:CRM) to $250 from $280 and maintained an Overweight rating. The firm noted that Q4 results narrowly exceeded consensus expectations; however, initial FY27 revenue growth guidance of 10.5% year-over-year came in modestly below Street expectations of approximately 11.1%. With investors intensely focused on the broader debate around AI-driven disruption and competitive positioning, Piper believes the slightly softer guide alone is unlikely to materially shift investor sentiment. That said, management reaffirmed its September Analyst Day expectations, highlighting strong bookings trends and improvements in customer attrition that are driving net new annualized recurring revenue (NNAOV) growth to outpace overall average order value (AOV) growth.
The same day, RBC Capital lowered its price target on Salesforce to $210 from $290 and maintained a Sector Perform rating. RBC described the quarter as decent overall, with revenue largely in line with consensus and Agentforce showing early signs of traction. However, the firm views the shares as “fully valued” at current levels and emphasized that the softer-than-expected forward guidance tempers enthusiasm. According to RBC, while AI product momentum remains an area of potential upside, the combination of valuation and moderated growth expectations supports a more balanced risk-reward outlook in the near term.
Founded in 1999 and headquartered in San Francisco, California, Salesforce provides a cloud-based customer relationship management platform designed to unify sales, service, marketing, and commerce functions. The company increasingly embeds AI and automation capabilities into its ecosystem to streamline workflows and enhance enterprise productivity across organizations of all sizes.
9. Block, Inc. (NYSE:XYZ)
EPS Growth in 3 years: 139.66%
Forward P/E: 12.57
On February 27, Oppenheimer raised its price target on Block, Inc. (NYSE:XYZ) to $89 from $85 and maintained an Outperform rating following a strong Q4 and constructive 2026 outlook. The firm emphasized a significant organizational restructuring, including a workforce reduction of more than 40%, aimed at operating with leaner, highly skilled teams and accelerating AI-driven automation. These actions are expected to support earnings targets for 2026 that exceed current consensus estimates. Cash App engagement strengthened in Q4, with 1 million incremental monthly transacting actives added, following 1 million additions in Q3.
Block, Inc. (NYSE:XYZ)’s fourth-quarter adjusted EPS was $0.65, with gross profit rising to $2.87 billion, driven by 33% year-over-year growth in the Cash App ecosystem. Gross payment volume reached $66.9 billion, slightly below forecasts, while operating expenses increased to $2.30 billion. Adjusted EBITDA improved to $930 million.
During its third-quarter 2025 earnings call, Block, Inc. (NYSE:XYZ) guided to Q4 2025 gross profit growth exceeding 19% year-over-year, reaching approximately $2.755 billion, alongside adjusted operating income of $560 million and a targeted 20% adjusted operating margin. Management raised full-year expectations accordingly, reflecting sustained profitability expansion.
Block, Inc. (NYSE:XYZ), founded in 2009 by Jack Dorsey and headquartered in Oakland, California, is a financial technology and services provider offering point-of-sale systems, digital payments, and consumer financial products.
8. Zoom Communications, Inc. (NASDAQ:ZM)
EPS Growth in 3 years: 162.70%
Forward P/E: 12.31
On February 26, Bernstein lowered its price target on Zoom Communications, Inc. (NASDAQ:ZM) to $88 from $90 and maintained a Market Perform rating. The firm noted that Q4 marked Zoom’s third consecutive beat of more than 1% versus midpoint guidance, signaling improved operating consistency. Performance was supported by stabilization in the online segment, 2.9% monthly churn, and an estimated $15 million FY26 revenue lift from last June’s price increase, with an additional annual SKU price adjustment set to roll out in mid-March.
Also on February 26, BTIG trimmed its price target on Zoom Communications, Inc. (NASDAQ:ZM) to $100 from $105 while reiterating a Buy rating. The firm highlighted accelerating Enterprise revenue growth and guidance that supports its view of approximately 5% revenue growth in FY27.
Previously, Zoom Communications, Inc. (NASDAQ:ZM) reported Q4 FY26 revenue of $1.25 billion, up 5.3% year-over-year (4.8% in constant currency) and $12 million above the high end of guidance. FY26 revenue grew 4.4%, representing a 130 basis point acceleration versus FY25, with FY27 revenue expected to exceed $5.06 billion at the midpoint (~4.1% YoY growth). FY26 free cash flow increased 6.4% to $1.9 billion. Under its $3.7 billion share repurchase authorization, Zoom bought back 3.8 million shares for approximately $324 million in Q4 and 36.3 million shares for roughly $2.7 billion year-to-date, with management intending to at least offset dilution through ongoing repurchases.
Zoom Communications, Inc. (NASDAQ:ZM), founded in 2011 and headquartered in San Jose, California, provides enterprise and consumer communications technology solutions, offering a unified platform spanning meetings, phone, contact center, and collaboration tools.
7. GigaCloud Technology Inc. (NASDAQ:GCT)
EPS Growth in 3 years: 138.44%
Forward P/E: 11.47
On February 27, Maxim Group raised its price target on GigaCloud Technology Inc. (NASDAQ:GCT) to $73 from $44 and reiterated a Buy rating. The firm highlighted that GigaCloud delivered Q4 results that exceeded expectations across key metrics, with revenue surpassing the high end of management’s guidance. Performance was driven in part by a turnaround in the Noble House brand and continued strength in international sales, underscoring improving operational execution and marketplace traction.
On February 26, 2026, GigaCloud Technology Inc. (NASDAQ:GCT) reported record fourth-quarter and full-year 2025 results. Q4 revenue increased 22.7% year-over-year to $362.7 million, while diluted EPS rose 36.8% to $1.04. For the full year, revenue grew 11.1% to $1.29 billion and diluted EPS advanced 17.7% to $3.59. Marketplace gross merchandise value (GMV) climbed 17.5% to $1.58 billion, supported by double-digit increases in active sellers and buyers.
Management highlighted robust cash generation and a debt-free balance sheet, ending 2025 with $416.9 million in cash and investments. GigaCloud Technology Inc. (NASDAQ:GCT) is executing a $111 million three-year share repurchase program approved in August 2025 and has already repurchased shares under the authorization. First-quarter 2026 revenue guidance of $330 million to $355 million underscores confidence in its diversified growth strategy and continued marketplace expansion.
GigaCloud Technology Inc. (NASDAQ:GCT), founded in 2006 and headquartered in El Monte, California, operates a B2B e-commerce marketplace focused on large, bulky, and non-standardized goods, including furniture, appliances, and fitness equipment, connecting global manufacturers with retailers through an integrated logistics platform.
6. Ategrity Specialty Insurance Company Holdings (NYSE:ASIC)
EPS Growth in 3 years: 173.81%
Forward P/E: 8.84
On February 24, JPMorgan raised its price target on Ategrity Specialty Insurance Company Holdings (NYSE:ASIC) to $27 from $25 and maintained an Overweight rating, increasing estimates following Q4 results. The firm views Ategrity as differentiated among specialty insurers due to its above-average premium growth trajectory and technology-enabled underwriting platform. The day prior, Citi also raised its price target to $27 from $26 and maintained a Buy rating, reflecting confidence in earnings momentum and growth visibility.
On February 12, Ategrity Specialty Insurance Company Holdings (NYSE:ASIC)’s board authorized a share repurchase program of up to $50 million of its outstanding common stock. The program allows management flexibility regarding timing, volume, and execution method, including open-market purchases, block trades, privately negotiated transactions, or Rule 10b5-1 plans. While the company is not obligated to repurchase a specific amount, the authorization provides a mechanism to opportunistically deploy capital, potentially enhance shareholder returns, and optimize capital structure in response to market conditions.
Ategrity Specialty Insurance Company Holdings (NYSE:ASIC) is a specialty insurance company focused on excess and surplus products for small- to medium-sized businesses across the United States, leveraging technology-driven underwriting capabilities to drive growth and efficiency.
5. Royalty Pharma plc (NASDAQ:RPRX)
EPS Growth in 3 years: 163.11%
Forward P/E: 8.65
On February 12, Goldman Sachs raised its price target on Royalty Pharma plc (NASDAQ:RPRX) to $51 from $45 and maintained a Buy rating after strong Q4 results. The firm noted that portfolio receipts and 2026 guidance exceeded expectations, implying 3%–8% year-over-year growth in royalty receipts. Goldman emphasized that the company remains positioned for long-term 10%+ top-line growth supported by synthetic royalty performance, ongoing commercial momentum, and favorable conditions in the royalty financing market. The company’s approximately $3.5 billion financial capacity supports continued active capital deployment.
For 2026, Royalty Pharma plc (NASDAQ:RPRX) guided portfolio receipts of $3.275 billion to $3.425 billion, implying royalty receipt growth of roughly 3%–8% based on the current portfolio and excluding future transactions. Milestones and other contractual receipts are expected to decline from $128 million in 2025 to approximately $60 million in 2026. Operating and professional costs are projected at 5%–6.5% of portfolio receipts, down from 8.9% in 2025 and 6.7% in Q4. Interest expense is expected to total approximately $350 million–$360 million, primarily weighted toward Q1 and Q3. Guidance excludes interest income on cash balances and anticipates approximately $85 million of equity performance awards in 2026.
During 2025, Royalty Pharma plc (NASDAQ:RPRX) announced that transaction value totaled $4.7 billion, with $2.6 billion deployed, including $887 million in Q4. The company returned $1.7 billion to shareholders through $1.2 billion in share repurchases and over $500 million in dividends, reducing weighted average share count by approximately 5%. The dividend was increased 7% for 2026, consistent with a mid-single-digit growth target, and management reiterated its dynamic capital allocation strategy, balancing royalty acquisitions, buybacks, and dividends.
Founded in 1996 and headquartered in New York City, Royalty Pharma plc (NASDAQ:RPRX) is the largest buyer of biopharmaceutical royalties globally and partners across the innovation ecosystem from academic institutions to leading pharmaceutical companies.
4. Blue Owl Technology Finance Corp. (NYSE:OTF)
EPS Growth in 3 years: 169.39%
Forward P/E: 8.32
On February 23, Truist lowered its price target on Blue Owl Technology Finance Corp. (NYSE:OTF) to $16 from $17 and maintained a Buy rating following Q4 results. The firm updated its model to reflect higher top-line expectations and increased expenses, noting that leverage rose faster than anticipated. The modest decline in estimates primarily reflects higher assumed debt costs and lower other income projections. The same day, Keefe Bruyette lowered its price target to $13 from $16 and maintained a Market Perform rating.
Blue Owl Technology Finance Corp. (NYSE:OTF) completed its NYSE listing in June 2025, becoming the largest publicly traded technology-focused BDC by total assets. The board declared a $0.35 regular quarterly dividend and five special dividends of $0.05 per share, supported by $0.40 of pre-listing spillover income. On February 18, the company reported Q4 adjusted net investment income of $0.30 per share and adjusted net income of $0.47 per share, generating an adjusted net income ROE of approximately 10.9%. GAAP results included $0.03 per share of accrued capital gains incentive fees. NAV per share increased to $17.33, up $0.06 quarter over quarter, and NAV has grown approximately 16% since inception, with a 35 basis point increase in the most recent quarter.
Founded in 2018 and headquartered in New York City, Blue Owl Technology Finance Corp. (NYSE:OTF) is a specialty finance company and business development company focused on providing debt and equity capital to U.S. technology-related businesses, particularly within the software sector.
3. Ethos Technologies Inc. (NASDAQ:LIFE)
EPS Growth in 3 years: 549.04%
Forward P/E: 6.40
On February 26, Citi raised the firm’s price target on Ethos Technologies Inc. (NASDAQ:LIFE) to $16 from $15 and maintained a Buy rating, viewing the company’s Q4 report as strong and indicative of sustained operational momentum. Citi believes the acceleration seen in Q4 has continued into Q1, reinforcing confidence in both top-line durability and earnings leverage.
The same day, Ethos Technologies Inc. (NASDAQ:LIFE) had reported Q4 revenue of $110.1 million, exceeding consensus expectations of $108.32 million. Management highlighted 65% year-over-year revenue growth in the quarter, reflecting significant scale expansion. CEO and Co-Founder Peter Colis emphasized that the results demonstrate not only exceptional top-line performance but also growing evidence of the company’s earnings power. Ethos also reached a milestone of 500,000 activated policies, underscoring adoption of its digital life insurance platform and reinforcing its mission to democratize access to coverage through a streamlined, no-medical-exam application process.
For Q1 2026, Ethos Technologies Inc. (NASDAQ:LIFE) expects total revenue between $144.0 million and $146.0 million, representing approximately 53% year-over-year growth at the midpoint, alongside adjusted EBITDA of $30.0 million to $32.0 million. For the full fiscal year 2026, the company projects total revenue of $510.0 million to $514.0 million, implying approximately 32% year-over-year growth at the midpoint, and adjusted EBITDA between $99.0 million and $103.0 million. The guidance reflects both sustained growth and expanding profitability as the company scales its technology-enabled platform.
Founded in 2016 and headquartered in Austin, Texas, Ethos Technologies Inc. (NASDAQ:LIFE) leverages AI and data science to modernize life insurance distribution through a three-sided platform serving consumers, agents, and carriers. With a forward price/earnings ratio of 6.4, Ethos Technologies is one of the best low priced growth stocks to buy right now.
2. Slide Insurance Holdings, Inc. (NASDAQ:SLDE)
EPS Growth in 3 years: 166.01%
Forward P/E: 5.78
On February 26, Piper Sandler analyst Paul Newsome raised the firm’s price target on Slide Insurance Holdings, Inc. (NASDAQ:SLDE) to $24 from $22 and reiterated an Overweight rating following quarterly results. The firm highlighted better-than-expected top-line growth versus both its model and consensus estimates, with 2026 guidance calling for revenue and earnings expansion ahead of Piper’s prior assumptions. The analyst characterized the quarter as solid, reflecting continued execution in underwriting and premium growth.
The same day, Morgan Stanley also raised its price target on Slide Insurance Holdings, Inc. (NASDAQ:SLDE) to $22 from $21 and maintained an Overweight rating. Updating estimates across the property and casualty group post-Q4, the firm emphasized that insurers demonstrating “differentiated” underwriting performance and durable margins are likely to outperform in a challenging pricing environment. While pricing pressure and AI-related competitive headwinds persist, Morgan Stanley believes underwriting discipline and margin resilience will be key drivers of relative share performance.
Slide Insurance Holdings, Inc. (NASDAQ:SLDE) is a technology-enabled property insurer leveraging artificial intelligence and big data analytics to optimize underwriting, pricing, and claims management. Founded in 2021 and headquartered in Tampa, Florida, the company focuses primarily on property insurance markets in Florida and South Carolina.
1. Criteo S.A. (NASDAQ:CRTO)
EPS Growth in 3 years: 164.75%
Forward P/E: 3.87
On February 12, DA Davidson analyst Tom White lowered the firm’s price target on Criteo S.A. (NASDAQ:CRTO) to $28.50 from $38 but maintained a Buy rating following a Q4 earnings miss. The company’s outlook also came in meaningfully below expectations, with management citing seasonal impacts from Retail Media client scope reductions, one-time tiered fee revenue recognized in January, and softer spending trends among fashion and department store advertisers.
That same day, Susquehanna also reduced its price target on Criteo S.A. (NASDAQ:CRTO) to $18 from $25 and kept a Neutral rating. The firm described Q4 results and guidance as mixed, noting sizable near-term revenue impacts from reduced scope with two retail media clients. However, Susquehanna expects these headwinds to moderate over the course of 2026, potentially stabilizing performance in the back half of the year.
Criteo S.A. (NASDAQ:CRTO), headquartered in Paris, France, is a global AI-driven commerce media platform that enables marketers and retailers to deliver personalized advertising across the open internet. Its solutions span retargeting, retail media, and performance advertising, with a focus on driving measurable sales outcomes and customer engagement. With an impressive forward price/earnings ratio of 3.87, Criteo is among the best low priced growth stocks to buy right now.
While we acknowledge the potential of CRTO as one of the best low priced growth stocks to buy right now, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CRTO and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 12 Best Data Storage Stocks to Buy Right Now and 10 Best Cruise Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
